Skip to main content
Premium Trial:

Request an Annual Quote

Decision Biomarkers Raises $7.6M in Series A Funding

NEW YORK, Feb. 7 (GenomeWeb News) - Decision Biomarkers closed a $7.6-million Series A financing round, the company said Friday.


Oxford Bioscience Partners led the round. Investors included Rock Maple Ventures, Fletcher Spaght Venture Partners, and a group of individual investors led by Coco Montagu.


The company said it would use the capital to "fast-track" its technology for reducing "overall drug development costs."


"This funding will be used to complete the product launch and achieve early sales," said CEO Roger Dowd in a statement.


The Waltham, Mass.-based company makes a fully automated platform that enables researchers to test up to 40 biomarkers at one time.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.